E102K (p.Glu102Lys) variant of NPHS2 (Podocin)

E102K (p.Glu102Lys) in NPHS2 (Podocin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes structural context.

E102K (p.Glu102Lys) variant details